ZYTIGA Drug Patents & Exclusivity Expiration

JANSSEN BIOTECH INC

ZYTIGA (abiraterone acetate) is an FDA-approved drug whose original license was filed by JANSSEN BIOTECH INC. There are 2 patents protecting this drug of which 0 are expired.

Drug Applications

Patents

Patent #PatentExpiration

8822438

(in 4689 days)

5604213

(in 783 days)

Exclusivity

Exclusivity CodeExclusivity End Date

NCE

(in 554 days)

I-663

(in 414 days)